CN Stock MarketDetailed Quotes

300391 Changjiang Pharmaceutical Group

Watchlist
  • 5.07
  • +0.18+3.68%
Trading Jul 25 10:15 CST
1.78BMarket Cap-2818P/E (TTM)

Changjiang Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-32.30%8.55M
-13.00%15.2M
47.42%13.83M
-91.87%12.79M
-93.73%12.63M
-83.77%17.47M
-91.93%9.38M
38.98%157.26M
142.49%201.3M
-22.75%107.7M
Notes receivable and accounts receivable
13.49%1.6B
14.72%1.64B
6.87%1.57B
-10.97%1.22B
-1.54%1.41B
3.32%1.43B
23.19%1.47B
12.45%1.37B
15.60%1.44B
14.87%1.38B
-Notes receivable
----
--100K
----
----
----
----
-96.26%80K
--30.69M
-66.25%1.84M
-61.16%5.11M
-Accounts receivable
13.49%1.6B
14.71%1.64B
6.88%1.57B
-8.93%1.22B
-1.41%1.41B
3.70%1.43B
23.40%1.47B
9.93%1.34B
15.96%1.43B
15.71%1.38B
Other receivables (including interest and dividends)
550.29%259.18M
676.28%243.94M
47.00%71.09M
30.61%55.35M
-7.12%39.86M
-40.39%31.42M
-80.96%48.36M
-73.40%42.38M
-72.49%42.91M
-67.70%52.72M
-Other receivable
----
----
----
30.61%55.35M
----
-40.39%31.42M
----
-73.40%42.38M
----
-67.70%52.72M
Contractual assets
-62.15%6.92M
-62.15%6.92M
39.73%25.59M
-0.18%18.28M
71.50%18.28M
71.50%18.28M
-89.95%18.31M
-91.97%18.31M
-95.07%10.66M
-92.34%10.66M
Advance payment
-38.62%145.42M
-6.10%120.76M
104.65%176.42M
10.70%400.97M
-8.80%236.93M
3.82%128.6M
-25.61%86.21M
104.07%362.2M
-8.08%259.78M
22.59%123.87M
Inventories
-24.98%53.7M
-12.80%51.86M
-52.58%56.91M
-1.34%136.77M
-54.99%71.59M
-69.55%59.47M
-39.21%120.02M
-47.51%138.63M
-18.47%159.07M
-22.36%195.35M
Receivable financing
----
32.28%238.11K
359.40%3.57M
-99.93%35K
-99.19%827.08K
-99.86%180K
-99.44%776.19K
-48.61%50.69M
35.36%102.6M
40.81%129.15M
Other current assets
-13.53%43.38M
-11.88%50.45M
-15.03%45.75M
38.87%70.36M
25.97%50.16M
1.42%57.25M
78.24%53.83M
78.10%50.67M
1,059.43%39.82M
100.36%56.45M
Total current assets
15.05%2.12B
22.22%2.13B
8.70%1.97B
-12.59%1.92B
-18.12%1.84B
-15.41%1.74B
-18.83%1.81B
-4.24%2.19B
-0.10%2.25B
-2.82%2.06B
Non Current assets
Fixed assets
----
----
----
-21.41%846.42M
----
-20.34%882.47M
----
99.06%1.08B
----
94.74%1.11B
Constru in process
----
----
----
7.25%188.23M
----
4.47%177.94M
----
-71.92%175.5M
----
-71.19%170.31M
Productive biological assets
----
-7.47%1.95M
-6.93%1.99M
-6.53%2.03M
-5.89%2.07M
-5.58%2.11M
-11.26%2.14M
-10.25%2.17M
-3.88%2.2M
3.37%2.23M
Intangible assets
139.39%98.5M
137.60%99.18M
135.27%99.86M
78.46%100.54M
-32.28%41.15M
-33.39%41.74M
-33.70%42.45M
-14.51%56.34M
-10.65%60.76M
-14.01%62.67M
Goodwill
-65.05%236.07M
-65.05%236.07M
-11.72%619.51M
-11.72%619.51M
-3.75%675.43M
-3.75%675.43M
0.00%701.73M
0.00%701.73M
0.00%701.73M
0.00%701.73M
Long deferred expense
----
----
----
-98.46%189.46K
-97.86%270.86K
-97.30%360.29K
-96.76%441.69K
-11.20%12.27M
-11.21%12.65M
-12.99%13.35M
Deferred tax assets
-59.52%16.47M
-58.63%16.47M
-52.04%17.56M
40.14%45.79M
-39.47%40.68M
-39.89%39.8M
-39.71%36.61M
-43.36%32.67M
27.70%67.2M
25.02%66.22M
Usufruct assets
-32.33%8.78M
-23.57%11.77M
-59.26%7.37M
-51.14%10.44M
-45.09%12.98M
-41.14%15.39M
--18.09M
--21.38M
--23.64M
254.33%26.15M
Other non current assets
-51.96%813.5K
78.51%3.02M
-63.43%2.69M
-63.43%2.69M
-23.23%1.69M
-66.66%1.69M
-74.03%7.36M
-63.97%7.36M
-99.58%2.21M
-99.09%5.08M
Total non current assets
-28.16%1.31B
-28.30%1.32B
-4.65%1.78B
-12.97%1.82B
-14.08%1.82B
-14.78%1.84B
-9.14%1.86B
2.88%2.09B
-15.57%2.12B
-16.18%2.16B
Total assets
-6.44%3.43B
-3.71%3.45B
1.93%3.74B
-12.78%3.73B
-16.16%3.67B
-15.09%3.58B
-14.19%3.67B
-0.90%4.28B
-8.26%4.38B
-10.15%4.21B
Liabilities
Current liabilities
Short term loan
-59.25%214.98M
-61.91%205.12M
-13.95%475.4M
-23.05%506.91M
-15.66%527.57M
8.71%538.5M
21.60%552.46M
33.58%658.73M
12.25%625.53M
9.42%495.36M
Notes payable and accounts payable
45.02%361.12M
79.66%358.51M
21.40%302.68M
-44.86%292.05M
-57.75%249.02M
-68.96%199.55M
-54.95%249.32M
-6.90%529.63M
7.16%589.35M
6.40%642.86M
-Notes payable
-57.76%2.8M
493.26%17.46M
255.38%19.26M
-64.05%42.21M
-94.82%6.62M
-97.23%2.94M
-95.27%5.42M
25.15%117.4M
65.62%127.89M
8.36%106.35M
-Accounts payable
47.82%358.33M
73.47%341.04M
16.20%283.42M
-39.39%249.84M
-47.47%242.4M
-63.35%196.61M
-44.43%243.9M
-13.23%412.22M
-2.39%461.46M
6.02%536.51M
Contract liabilities
-31.47%13.57M
17.08%16.95M
80.11%34.02M
23.24%26.19M
42.41%19.81M
9.09%14.48M
-12.69%18.89M
35.00%21.25M
-61.18%13.91M
-52.79%13.27M
Salaries payable
-0.76%22.11M
-10.86%18.52M
48.27%25.96M
9.90%23.5M
9.28%22.28M
-22.67%20.78M
-8.49%17.51M
-1.72%21.38M
7.30%20.39M
42.33%26.87M
Taxs payable
-5.95%124.88M
-3.59%127.46M
5.44%135.99M
2.10%132.77M
1.87%132.78M
6.26%132.2M
-8.98%128.98M
0.09%130.04M
21.10%130.35M
14.85%124.42M
Other payable (including interest and dividends)
71.94%1.12B
84.00%1.04B
79.11%742.57M
-18.12%646.19M
-13.28%650.13M
-26.49%567.45M
-56.25%414.59M
-19.28%789.22M
-43.88%749.66M
-40.44%771.94M
-Interest payable
--28.74M
--20.44M
----
----
----
----
----
----
----
----
-Other payable
----
----
----
-18.12%646.19M
----
-26.49%567.45M
----
-19.25%789.22M
----
-40.38%771.94M
Non current liabilities due within one year
162.73%106.38M
53.21%108.03M
68.34%60.18M
118.36%67.78M
29.11%40.49M
124.96%70.51M
--35.75M
--31.04M
--31.36M
-73.16%31.34M
Other current liabilities
-71.55%553.15K
8.66%1.72M
239.87%4.46M
-62.33%3.02M
15.70%1.94M
-58.88%1.59M
-46.63%1.31M
333.39%8.03M
22.34%1.68M
-8.29%3.86M
Total current liabilities
19.31%1.96B
21.71%1.88B
25.55%1.78B
-22.42%1.7B
-23.97%1.64B
-26.77%1.55B
-33.71%1.42B
-0.89%2.19B
-17.06%2.16B
-19.75%2.11B
Current liabilities
Long term loan
47.17%504.48M
54.76%518.89M
-13.05%317.39M
-21.25%315M
-6.88%342.79M
7.97%335.29M
8.96%365M
19.40%400M
8.27%368.12M
-8.66%310.55M
Long term account payable
----
----
----
-99.65%4.27K
----
-99.55%538.33K
----
-98.95%1.23M
----
-45.06%119.55M
Estimate liabilities
-83.19%676.45K
-83.19%676.45K
--29.38M
-68.55%4.03M
-69.70%4.03M
-65.28%4.03M
----
1.48%12.8M
4.60%13.29M
-3.31%11.59M
Deferred tax liabilities
3.00%7.1M
0.00%7.1M
-11.66%6.55M
-12.68%6.72M
-15.77%6.9M
-18.42%7.1M
-19.79%7.42M
-21.36%7.7M
-20.99%8.19M
-20.45%8.71M
Long term deferred income
-3.67%15.16M
-4.15%15.24M
-4.11%15.41M
-31.23%15.57M
-32.10%15.74M
-32.94%15.9M
-33.84%16.07M
-8.97%22.64M
-8.94%23.18M
-9.08%23.71M
Lease liabilities
-69.95%6.25M
-8.68%5.45M
-73.60%5.56M
-74.09%5.58M
-2.46%20.79M
-71.75%5.97M
--21.04M
--21.52M
--21.32M
314.11%21.15M
Other non current liabilities
638.09%650.31K
723.87%650.31K
--78.93K
--78.93K
--88.11K
--78.93K
----
----
----
----
Total non current liabilities
36.84%534.32M
48.55%548.01M
-29.10%374.36M
-25.52%346.98M
-29.47%390.48M
-25.51%368.92M
6.02%527.98M
-6.80%465.89M
-8.66%553.64M
-19.04%495.26M
Total liabilities
22.67%2.5B
26.88%2.43B
10.73%2.16B
-22.97%2.05B
-25.09%2.03B
-26.53%1.91B
-26.21%1.95B
-1.98%2.66B
-15.48%2.72B
-19.62%2.61B
Shareholders equity
Paid-in capital
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
Capital reserve funds
0.01%788.17M
0.01%788.17M
-0.25%788.07M
-0.25%788.07M
-0.25%788.07M
-0.25%788.07M
0.00%790.05M
0.00%790.05M
0.00%790.05M
0.00%790.05M
Surplus reserve funds
0.00%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
-5.60%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
5.93%19.45M
0.00%18.36M
Retained profit
-166.26%-1.01B
-170.08%-961.75M
-54.54%-471.94M
-1.93%-380.31M
-18.32%-379.05M
-6.99%-356.09M
-7.07%-305.39M
-25.23%-373.09M
0.66%-320.37M
12.86%-332.82M
Other composite income
----
----
----
----
----
----
----
-5.01%-143.88K
882.32%918.75K
-19.34%-149.27K
Specific reserves
----
----
----
----
----
----
----
-42.51%555.95K
50.97%348.97K
--507.73K
Shareholders equity without minority interests
-81.02%147.62M
-75.63%195.12M
-19.75%684.82M
-1.22%776.46M
-7.49%777.71M
-3.10%800.67M
-2.38%853.35M
-8.77%786.06M
0.52%840.73M
6.38%826.28M
Minority interests
-7.89%788.59M
-4.83%822.2M
3.49%902.24M
8.68%910.59M
4.58%856.09M
10.34%863.95M
13.71%871.79M
12.11%837.86M
13.75%818.6M
16.38%783.01M
Total shareholder equity
-42.70%936.2M
-38.89%1.02B
-8.00%1.59B
3.89%1.69B
-1.54%1.63B
3.44%1.66B
5.14%1.73B
0.93%1.62B
6.64%1.66B
11.03%1.61B
Total liabilityies and equity
-6.44%3.43B
-3.71%3.45B
1.93%3.74B
-12.78%3.73B
-16.16%3.67B
-15.09%3.58B
-14.19%3.67B
-0.90%4.28B
-8.26%4.38B
-10.15%4.21B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
China Audit Asia Pacific Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Asia Pacific Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -32.30%8.55M-13.00%15.2M47.42%13.83M-91.87%12.79M-93.73%12.63M-83.77%17.47M-91.93%9.38M38.98%157.26M142.49%201.3M-22.75%107.7M
Notes receivable and accounts receivable 13.49%1.6B14.72%1.64B6.87%1.57B-10.97%1.22B-1.54%1.41B3.32%1.43B23.19%1.47B12.45%1.37B15.60%1.44B14.87%1.38B
-Notes receivable ------100K-----------------96.26%80K--30.69M-66.25%1.84M-61.16%5.11M
-Accounts receivable 13.49%1.6B14.71%1.64B6.88%1.57B-8.93%1.22B-1.41%1.41B3.70%1.43B23.40%1.47B9.93%1.34B15.96%1.43B15.71%1.38B
Other receivables (including interest and dividends) 550.29%259.18M676.28%243.94M47.00%71.09M30.61%55.35M-7.12%39.86M-40.39%31.42M-80.96%48.36M-73.40%42.38M-72.49%42.91M-67.70%52.72M
-Other receivable ------------30.61%55.35M-----40.39%31.42M-----73.40%42.38M-----67.70%52.72M
Contractual assets -62.15%6.92M-62.15%6.92M39.73%25.59M-0.18%18.28M71.50%18.28M71.50%18.28M-89.95%18.31M-91.97%18.31M-95.07%10.66M-92.34%10.66M
Advance payment -38.62%145.42M-6.10%120.76M104.65%176.42M10.70%400.97M-8.80%236.93M3.82%128.6M-25.61%86.21M104.07%362.2M-8.08%259.78M22.59%123.87M
Inventories -24.98%53.7M-12.80%51.86M-52.58%56.91M-1.34%136.77M-54.99%71.59M-69.55%59.47M-39.21%120.02M-47.51%138.63M-18.47%159.07M-22.36%195.35M
Receivable financing ----32.28%238.11K359.40%3.57M-99.93%35K-99.19%827.08K-99.86%180K-99.44%776.19K-48.61%50.69M35.36%102.6M40.81%129.15M
Other current assets -13.53%43.38M-11.88%50.45M-15.03%45.75M38.87%70.36M25.97%50.16M1.42%57.25M78.24%53.83M78.10%50.67M1,059.43%39.82M100.36%56.45M
Total current assets 15.05%2.12B22.22%2.13B8.70%1.97B-12.59%1.92B-18.12%1.84B-15.41%1.74B-18.83%1.81B-4.24%2.19B-0.10%2.25B-2.82%2.06B
Non Current assets
Fixed assets -------------21.41%846.42M-----20.34%882.47M----99.06%1.08B----94.74%1.11B
Constru in process ------------7.25%188.23M----4.47%177.94M-----71.92%175.5M-----71.19%170.31M
Productive biological assets -----7.47%1.95M-6.93%1.99M-6.53%2.03M-5.89%2.07M-5.58%2.11M-11.26%2.14M-10.25%2.17M-3.88%2.2M3.37%2.23M
Intangible assets 139.39%98.5M137.60%99.18M135.27%99.86M78.46%100.54M-32.28%41.15M-33.39%41.74M-33.70%42.45M-14.51%56.34M-10.65%60.76M-14.01%62.67M
Goodwill -65.05%236.07M-65.05%236.07M-11.72%619.51M-11.72%619.51M-3.75%675.43M-3.75%675.43M0.00%701.73M0.00%701.73M0.00%701.73M0.00%701.73M
Long deferred expense -------------98.46%189.46K-97.86%270.86K-97.30%360.29K-96.76%441.69K-11.20%12.27M-11.21%12.65M-12.99%13.35M
Deferred tax assets -59.52%16.47M-58.63%16.47M-52.04%17.56M40.14%45.79M-39.47%40.68M-39.89%39.8M-39.71%36.61M-43.36%32.67M27.70%67.2M25.02%66.22M
Usufruct assets -32.33%8.78M-23.57%11.77M-59.26%7.37M-51.14%10.44M-45.09%12.98M-41.14%15.39M--18.09M--21.38M--23.64M254.33%26.15M
Other non current assets -51.96%813.5K78.51%3.02M-63.43%2.69M-63.43%2.69M-23.23%1.69M-66.66%1.69M-74.03%7.36M-63.97%7.36M-99.58%2.21M-99.09%5.08M
Total non current assets -28.16%1.31B-28.30%1.32B-4.65%1.78B-12.97%1.82B-14.08%1.82B-14.78%1.84B-9.14%1.86B2.88%2.09B-15.57%2.12B-16.18%2.16B
Total assets -6.44%3.43B-3.71%3.45B1.93%3.74B-12.78%3.73B-16.16%3.67B-15.09%3.58B-14.19%3.67B-0.90%4.28B-8.26%4.38B-10.15%4.21B
Liabilities
Current liabilities
Short term loan -59.25%214.98M-61.91%205.12M-13.95%475.4M-23.05%506.91M-15.66%527.57M8.71%538.5M21.60%552.46M33.58%658.73M12.25%625.53M9.42%495.36M
Notes payable and accounts payable 45.02%361.12M79.66%358.51M21.40%302.68M-44.86%292.05M-57.75%249.02M-68.96%199.55M-54.95%249.32M-6.90%529.63M7.16%589.35M6.40%642.86M
-Notes payable -57.76%2.8M493.26%17.46M255.38%19.26M-64.05%42.21M-94.82%6.62M-97.23%2.94M-95.27%5.42M25.15%117.4M65.62%127.89M8.36%106.35M
-Accounts payable 47.82%358.33M73.47%341.04M16.20%283.42M-39.39%249.84M-47.47%242.4M-63.35%196.61M-44.43%243.9M-13.23%412.22M-2.39%461.46M6.02%536.51M
Contract liabilities -31.47%13.57M17.08%16.95M80.11%34.02M23.24%26.19M42.41%19.81M9.09%14.48M-12.69%18.89M35.00%21.25M-61.18%13.91M-52.79%13.27M
Salaries payable -0.76%22.11M-10.86%18.52M48.27%25.96M9.90%23.5M9.28%22.28M-22.67%20.78M-8.49%17.51M-1.72%21.38M7.30%20.39M42.33%26.87M
Taxs payable -5.95%124.88M-3.59%127.46M5.44%135.99M2.10%132.77M1.87%132.78M6.26%132.2M-8.98%128.98M0.09%130.04M21.10%130.35M14.85%124.42M
Other payable (including interest and dividends) 71.94%1.12B84.00%1.04B79.11%742.57M-18.12%646.19M-13.28%650.13M-26.49%567.45M-56.25%414.59M-19.28%789.22M-43.88%749.66M-40.44%771.94M
-Interest payable --28.74M--20.44M--------------------------------
-Other payable -------------18.12%646.19M-----26.49%567.45M-----19.25%789.22M-----40.38%771.94M
Non current liabilities due within one year 162.73%106.38M53.21%108.03M68.34%60.18M118.36%67.78M29.11%40.49M124.96%70.51M--35.75M--31.04M--31.36M-73.16%31.34M
Other current liabilities -71.55%553.15K8.66%1.72M239.87%4.46M-62.33%3.02M15.70%1.94M-58.88%1.59M-46.63%1.31M333.39%8.03M22.34%1.68M-8.29%3.86M
Total current liabilities 19.31%1.96B21.71%1.88B25.55%1.78B-22.42%1.7B-23.97%1.64B-26.77%1.55B-33.71%1.42B-0.89%2.19B-17.06%2.16B-19.75%2.11B
Current liabilities
Long term loan 47.17%504.48M54.76%518.89M-13.05%317.39M-21.25%315M-6.88%342.79M7.97%335.29M8.96%365M19.40%400M8.27%368.12M-8.66%310.55M
Long term account payable -------------99.65%4.27K-----99.55%538.33K-----98.95%1.23M-----45.06%119.55M
Estimate liabilities -83.19%676.45K-83.19%676.45K--29.38M-68.55%4.03M-69.70%4.03M-65.28%4.03M----1.48%12.8M4.60%13.29M-3.31%11.59M
Deferred tax liabilities 3.00%7.1M0.00%7.1M-11.66%6.55M-12.68%6.72M-15.77%6.9M-18.42%7.1M-19.79%7.42M-21.36%7.7M-20.99%8.19M-20.45%8.71M
Long term deferred income -3.67%15.16M-4.15%15.24M-4.11%15.41M-31.23%15.57M-32.10%15.74M-32.94%15.9M-33.84%16.07M-8.97%22.64M-8.94%23.18M-9.08%23.71M
Lease liabilities -69.95%6.25M-8.68%5.45M-73.60%5.56M-74.09%5.58M-2.46%20.79M-71.75%5.97M--21.04M--21.52M--21.32M314.11%21.15M
Other non current liabilities 638.09%650.31K723.87%650.31K--78.93K--78.93K--88.11K--78.93K----------------
Total non current liabilities 36.84%534.32M48.55%548.01M-29.10%374.36M-25.52%346.98M-29.47%390.48M-25.51%368.92M6.02%527.98M-6.80%465.89M-8.66%553.64M-19.04%495.26M
Total liabilities 22.67%2.5B26.88%2.43B10.73%2.16B-22.97%2.05B-25.09%2.03B-26.53%1.91B-26.21%1.95B-1.98%2.66B-15.48%2.72B-19.62%2.61B
Shareholders equity
Paid-in capital 0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M
Capital reserve funds 0.01%788.17M0.01%788.17M-0.25%788.07M-0.25%788.07M-0.25%788.07M-0.25%788.07M0.00%790.05M0.00%790.05M0.00%790.05M0.00%790.05M
Surplus reserve funds 0.00%18.36M0.00%18.36M0.00%18.36M0.00%18.36M-5.60%18.36M0.00%18.36M0.00%18.36M0.00%18.36M5.93%19.45M0.00%18.36M
Retained profit -166.26%-1.01B-170.08%-961.75M-54.54%-471.94M-1.93%-380.31M-18.32%-379.05M-6.99%-356.09M-7.07%-305.39M-25.23%-373.09M0.66%-320.37M12.86%-332.82M
Other composite income -----------------------------5.01%-143.88K882.32%918.75K-19.34%-149.27K
Specific reserves -----------------------------42.51%555.95K50.97%348.97K--507.73K
Shareholders equity without minority interests -81.02%147.62M-75.63%195.12M-19.75%684.82M-1.22%776.46M-7.49%777.71M-3.10%800.67M-2.38%853.35M-8.77%786.06M0.52%840.73M6.38%826.28M
Minority interests -7.89%788.59M-4.83%822.2M3.49%902.24M8.68%910.59M4.58%856.09M10.34%863.95M13.71%871.79M12.11%837.86M13.75%818.6M16.38%783.01M
Total shareholder equity -42.70%936.2M-38.89%1.02B-8.00%1.59B3.89%1.69B-1.54%1.63B3.44%1.66B5.14%1.73B0.93%1.62B6.64%1.66B11.03%1.61B
Total liabilityies and equity -6.44%3.43B-3.71%3.45B1.93%3.74B-12.78%3.73B-16.16%3.67B-15.09%3.58B-14.19%3.67B-0.90%4.28B-8.26%4.38B-10.15%4.21B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion------Unqualified opinion
Auditor ----------China Audit Asia Pacific Certified Public Accountants (Special General Partnership)------China Audit Asia Pacific Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg